Original article
Dilek Kolat, Senator for Health, Care and Equality from Berlin, and Frank Ahrend, member of the management board of AOK Nordost and responsible for, jointly position themselves on the topic of “20 years of the Berlin project – care with the plus” in an interview with “Monitor Healthcare Research”. the “Central Services and Care” department.
04.04.2019
The Institute for Community Medicine at Greifswald University Medical Center under the leadership of its Managing Director, Prof. Dr. med. Wolfgang Hoffmann, not followed. On the occasion of the second edition of the “Germany-wide forecast of population-related morbidity expectancy for common cancers. Effects on care”, Hoffmann presented current figures on the future development of prevalence and incidence of cancer at the capital congress, as well as a comparison to his first work for the DGHO, the study “Challenge of demographic change” published in 2013. Stocktaking and future requirements for oncological care”. The result: The prediction at the time for the year 2020 - based on the data available at the time from 2008 - was amazingly correct: except for just a few percent!
04.04.2019
Prof. Dr. Volker Amelung, Hans-Holger Bleß and Ralph Lägel have been working together since the beginning of the year at inav, a research and consulting institute active in the healthcare sector with a focus on healthcare research, innovative healthcare concepts, digital health, market access and reimbursement. In this way, the trio addresses three fields of innovation in the German healthcare system: on the one hand, digital health, on the other hand, the innovation fund and, thirdly, innovations in the areas of pharmaceuticals and medical devices, in which there has been a tremendous amount of change, especially in recent years. “Monitor Healthcare Research” wants to shed more light on these fields in an interview: Let’s start with the highly topical topic of digitalization due to the Digital Healthcare Act, for which Ralph Lägel is responsible for the content at inav.
04.04.2019
Digitalization offers great opportunities to provide patients with better care, as several model projects show. To be successful, doctors don't just need large, high-quality data pools and algorithms. Data protection and data security play an important role, but should not become a fig leaf to reject everything new.
04.04.2019
More than every second person in Germany, specifically 54.3% of the population, has limited health literacy - according to the results of a study by Bielefeld University. This means that the majority of the population in Germany finds it difficult to find, understand, evaluate and use health-related information.
04.04.2019
It is intended to advance healthcare and promote innovation - the Innovatinos Fund. With a total volume of 820 million euros, 290 projects were funded in the first phase between 2016 and 2018. The Federal Ministry of Health has now initiated a scientific evaluation of the funding from the Innovation Fund. Is the fund a suitable instrument to further develop healthcare? The authors of the interim report - the final report is to be submitted to the German Bundestag by March 31, 2021 - answered this question with yes.
04.04.2019
Christian Klose, previously permanent representative of Department 5 “Digitalization and Innovation” in the Federal Ministry of Health and since the beginning of April sub-department head in the department headed by Dr. Gottfried Ludewig, gave an insight into the timetable of the digitalization law, which is about to be finalized, at a lecture evening on the occasion of the DNVF SpringSchool: The BMG, which has almost 800 employees, is currently in the process of getting this law off the ground. The draft bill for this proposed law (see p. 23), which should actually have been ready at the turn of the year, is now available.
04.04.2019
Increasing the efficiency of clinical studies is possible with the help of patient health data from various sources. The US Food and Drug Administration (FDA) is convinced of this theory, which is still controversial in this country. But what does the data have to be like in order to provide valid results and evidence? And how should these results be incorporated into the FDA's regulatory decision-making? The US authority addresses these questions with some interesting answers in the “Framework for FDA'S Real-World Evidence Program”.
04.04.2019
What does big data mean for the EU regulation of national health systems? The newly founded task force of the HMA (Heads of Medicines Agencies) and EMA (European Medicines Agencies) is addressing this question. What data is generated, in what quality, and what standards are necessary to use this data to manage the healthcare system? These are some aspects of the topic that the task force has developed in various workstreams. She has summarized the results in a report, including several core recommendations and two studies on how industry and the responsible national supervisory authorities (National Competent Authorities, NCAs) deal with big data.
04.04.2019
When it comes to health economics issues in Germany, you come to Prof. Dr. Jürgen Wasem, the holder of the Alfried Krupp von Bohlen and Halbach Endowed Chair for Medical Management at the University of Duisburg-Essen. On countless podiums and as chairman of the advisory board of various specialist committees, he always raises his voice when he wants to point out undesirable developments from his economic perspective or show how our health system can become even better; for example, by becoming more open to innovation.